223 related articles for article (PubMed ID: 8328993)
21. [Importance of depot neuroleptics in psychiatry].
Arató M; Erdös A
Orv Hetil; 1977 Oct; 118(41):2453-6. PubMed ID: 335322
[No Abstract] [Full Text] [Related]
22. Kinetics of fluphenazine after fluphenazine dihydrochloride, enanthate and decanoate administration to man.
Curry SH; Whelpton R; de Schepper PJ; Vranckx S; Schiff AA
Br J Clin Pharmacol; 1979 Apr; 7(4):325-31. PubMed ID: 444352
[TBL] [Abstract][Full Text] [Related]
23. Persistence of fluphenazine in plasma after decanoate withdrawal.
Gitlin MJ; Midha KK; Fogelson D; Nuechterlein K
J Clin Psychopharmacol; 1988 Feb; 8(1):53-6. PubMed ID: 3351000
[TBL] [Abstract][Full Text] [Related]
24. Fluphenazine enanthate and fluphenazine decanoate: intramuscular injection and esterification as requirements for slow - release characteristics in dogs.
Dreyfuss J; Shaw JM; Ross JJ
J Pharm Sci; 1976 Sep; 65(9):1310-5. PubMed ID: 966144
[TBL] [Abstract][Full Text] [Related]
25. [Determination of cis(Z)-clopenthixol and fluphenazine in whole blood and plasma by high-performance liquid chromatography with an internal standard].
Viala A; Hou N; Durand A; Ba B; Aaes-Jørgensen T; Jørgensen A
J Pharm Belg; 1983; 38(6):299-303. PubMed ID: 6674473
[No Abstract] [Full Text] [Related]
26. Sensitive gas-chromatographic determination of fluphenazine in human plasma.
Franklin M; Wiles DH; Harvey DJ
Clin Chem; 1978 Jan; 24(1):41-4. PubMed ID: 618664
[TBL] [Abstract][Full Text] [Related]
27. Fluphenazine plasma levels and clinical response.
Mavroidis ML; Kanter DR; Hirschowitz J; Garver DL
J Clin Psychiatry; 1984 Sep; 45(9):370-3. PubMed ID: 6381472
[TBL] [Abstract][Full Text] [Related]
28. [Results of therapy with Lyogen-Depot in schizophrenic diseases].
Friemert K; Beier R; Vehreschild T
Psychiatr Neurol Med Psychol (Leipz); 1974 Jun; 26(6):374-7. PubMed ID: 4849639
[No Abstract] [Full Text] [Related]
29. [Prolonged treatment of schizophrenic psychoses with depot-fluphenazine ("lyogen decanoate")].
Bohacek N; Mihovilović M
Neuropsihijatrija; 1968; 16(3):69-73. PubMed ID: 5195835
[No Abstract] [Full Text] [Related]
30. [Fluphenazine oenanthate ("Moditen-Retard" N.D.) chemistry and pharmacology].
Viala A
Encephale; 1970; ():Suppl:3-9. PubMed ID: 5458710
[No Abstract] [Full Text] [Related]
31. Changing from oral to depot fluphenazine.
Yadalam KG; Simpson GM
J Clin Psychiatry; 1988 Sep; 49(9):346-8. PubMed ID: 3417620
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of peroxyoxalate chemiluminescence postcolumn detection of fluphenazine in urine and blood plasma using high performance liquid chromatography.
Mann B; Grayeski ML
Biomed Chromatogr; 1991 Jan; 5(1):47-52. PubMed ID: 2032022
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of ursodeoxycholic acid bioavailability from immediate- and sustained-release preparations using gas chromatography-mass spectrometry and high-performance liquid chromatography.
Scalia S; Scagliarini R; Pazzi P
Arzneimittelforschung; 2000 Feb; 50(2):129-34. PubMed ID: 10719615
[TBL] [Abstract][Full Text] [Related]
34. [New perspectives offered by an injectable delayed-action neuroleptic: fluphenazine enanthate].
Lambert PA; Midenet M; Midenet J; Marcou G; Bouchardy M
Ann Med Psychol (Paris); 1966 May; 124(5):702-7. PubMed ID: 5941462
[No Abstract] [Full Text] [Related]
35. The use of capillary high performance liquid chromatography with electrospray mass spectrometry for the analysis of small volume blood samples from serially bled mice to determine the pharmacokinetics of early discovery compounds.
Fraser IJ; Dear GJ; Plumb R; L'Affineur M; Fraser D; Skippen AJ
Rapid Commun Mass Spectrom; 1999; 13(23):2366-75. PubMed ID: 10567936
[TBL] [Abstract][Full Text] [Related]
36. Early unwanted effects of fluphenazine esters related to plasma fluphenazine concentrations in schizophrenic patients.
Altamura AC; Curry SH; Montgomery S; Wiles DH
Psychopharmacology (Berl); 1985; 87(1):30-3. PubMed ID: 3933035
[TBL] [Abstract][Full Text] [Related]
37. The prolonged action of fluphenazine enanthate in oil after depot injection.
Laffan RJ; High JP; Burke JC
Int J Neuropsychiatry; 1965 Aug; 1(4):300-6. PubMed ID: 5863505
[No Abstract] [Full Text] [Related]
38. [Remarks on the action of Moditen-retard and Modecate. Apropos of 65 cases].
Scherrer P; Quiniou-Vidalenc
Ann Med Psychol (Paris); 1976 Nov; 2(4):642-56. PubMed ID: 1020862
[No Abstract] [Full Text] [Related]
39. [Clinical and ambulatory experiences with fluphenazine decanoate lyogen depot in prolonged therapy of psychiatric disorders].
Moldenhauer B
Med Welt; 1970 Jun; 25():1150-4. PubMed ID: 5512636
[No Abstract] [Full Text] [Related]
40. [Results of treatment by Moditen Depot in outpatients' wards in the South Moravian Region (author's transl)].
Rektor L; Blazek J
Cesk Psychiatr; 1980; 76(6):369-75. PubMed ID: 7471277
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
